Oct 3 |
New positive donidalorsen data to be presented at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
|
Oct 2 |
IONS' Rare Neurology Disorder Candidate Gets FDA's Fast Track Tag
|
Oct 1 |
Ionis gets U.S. FDA fast track designation for its Alexander disease treatment
|
Oct 1 |
Zilganersen granted U.S. FDA Fast Track designation for people living with Alexander disease
|
Sep 12 |
The Brawl Taking Shape Over Pfizer’s Multibillion-Dollar Heart Monopoly
|
Sep 11 |
Ionis Stock Drops 12% on Pricing of $500M Common Stock Offering
|
Sep 10 |
Ionis announces pricing of $500.3 million public offering
|
Sep 9 |
Ionis announces proposed public offering of common stock
|
Sep 5 |
Why Is Zoetis (ZTS) Up 1.4% Since Last Earnings Report?
|
Sep 4 |
Theravance Bio (TBPH) Up 2.2% Since Last Earnings Report: Can It Continue?
|